Literature DB >> 5034858

Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia.

P C Gillette, L L Hill, K A Starling, D J Fernbach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5034858     DOI： 10.1016/s0022-3476(72)80388-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  3 in total

1.  Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.

Authors:  Netanya I Pollock; Yael Flamand; Jia Zhu; Kate Millington; Kristen Stevenson; Lewis B Silverman; Lynda M Vrooman; Laurie E Cohen
Journal:  Pediatr Blood Cancer       Date:  2021-12-21       Impact factor: 3.838

2.  The effect of E. coli L-asparaginase on oral glucose tolerance and insulin release in man.

Authors:  R L Lavine; I Brodsky; C D Garofano; L I Rose
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

3.  [Extracorporeal treatment with L-asparaginase (author's transl)].

Authors:  H Pralle; H Löffler
Journal:  Blut       Date:  1977-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.